tiprankstipranks
Advertisement
Advertisement

HRTX Stock Latest News

Heron Therapeutics Earnings Call: Growth Meets New Risks
Company AnnouncementsHeron Therapeutics Earnings Call: Growth Meets New Risks
4d ago
HRTX
Allstate, CHMI, HRTX, AppLovin, BCE Trending With Analysts
PremiumWeekend Updates
Allstate, CHMI, HRTX, AppLovin, BCE Trending With Analysts
8d ago
ALL
APP
Heron Therapeutics Extends Tax Benefit Preservation Plan Timeline
PremiumCompany Announcements
Heron Therapeutics Extends Tax Benefit Preservation Plan Timeline
9d ago
8K
HRTX
Heron Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Heron Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
12d ago
HRTX
Heron Therapeutics Faces Nasdaq Delisting Risk as Share Price Falls Below $1 Threshold
PremiumCompany Announcements
Heron Therapeutics Faces Nasdaq Delisting Risk as Share Price Falls Below $1 Threshold
12d ago
HRTX
HRTX Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsHRTX Upcoming Earnings Report: What to Expect?
15d ago
HRTX
Heron Therapeutics Faces Nasdaq Minimum Bid Price Deficiency
Premium
Company Announcements
Heron Therapeutics Faces Nasdaq Minimum Bid Price Deficiency
2M ago
8K
HRTX
Heron Shareholders Approve Directors, Incentive Plans, Tax Measures
Premium
Company Announcements
Heron Shareholders Approve Directors, Incentive Plans, Tax Measures
2M ago
8K
HRTX
X4, TripAdvisor, Heron, DigitalOcean, Shake Shack Trending
PremiumWeekend Updates
X4, TripAdvisor, Heron, DigitalOcean, Shake Shack Trending
3M ago
DOCN
HRTX
Heron Therapeutics price target lowered to $2 from $4 at H.C. Wainwright
PremiumThe Fly
Heron Therapeutics price target lowered to $2 from $4 at H.C. Wainwright
3M ago
HRTX
Heron Therapeutics Appeals Ruling Invalidating CINVANTI Patents
PremiumCompany Announcements
Heron Therapeutics Appeals Ruling Invalidating CINVANTI Patents
3M ago
8K
HRTX
Heron Therapeutics downgraded at Needham after Cinvanti patents invalidated
PremiumThe Fly
Heron Therapeutics downgraded at Needham after Cinvanti patents invalidated
3M ago
HRTX
Heron Therapeutics downgraded to Hold from Buy at Needham
PremiumThe FlyHeron Therapeutics downgraded to Hold from Buy at Needham
3M ago
HRTX
Heron announces U.S. district court decision regarding Cinvanti patents
Premium
The Fly
Heron announces U.S. district court decision regarding Cinvanti patents
3M ago
HRTX
Heron Therapeutics Faces Tight Covenant Constraints That Threaten Liquidity and Strategic Flexibility
Premium
Company Announcements
Heron Therapeutics Faces Tight Covenant Constraints That Threaten Liquidity and Strategic Flexibility
3M ago
HRTX
Heron Therapeutics Signals Recovery Despite Soft Q1
PremiumCompany Announcements
Heron Therapeutics Signals Recovery Despite Soft Q1
3M ago
HRTX
Heron Therapeutics price target lowered to $4 from $6 at H.C. Wainwright
PremiumThe Fly
Heron Therapeutics price target lowered to $4 from $6 at H.C. Wainwright
3M ago
HRTX
Heron Therapeutics reports Q1 EPS (4c), consensus (2c)
PremiumThe Fly
Heron Therapeutics reports Q1 EPS (4c), consensus (2c)
3M ago
HRTX
Heron Therapeutics backs FY26 revenue view $173M-$183M, consensus $174.73M
PremiumThe Fly
Heron Therapeutics backs FY26 revenue view $173M-$183M, consensus $174.73M
3M ago
HRTX
HRTX Earnings this Week: How Will it Perform?
PremiumPre-EarningsHRTX Earnings this Week: How Will it Perform?
4M ago
HRTX
Heron Therapeutics (HRTX): Buy Rating on Expanding Hospital Product Adoption and Attractive Risk‑Reward
Premium
Ratings
Heron Therapeutics (HRTX): Buy Rating on Expanding Hospital Product Adoption and Attractive Risk‑Reward
4M ago
HRTX
Heron Therapeutics Strengthens Executive Contracts Amid Strategic Focus
Premium
Company Announcements
Heron Therapeutics Strengthens Executive Contracts Amid Strategic Focus
5M ago
8K
HRTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >